Identification |
Name: | 4-Acridinecarboxamide,N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo- |
Synonyms: | Elacridar;GF 120918;GG 918;GW 0918;N-[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide; |
CAS: | 143664-11-3 |
Molecular Formula: | C34H33N3O5 |
Molecular Weight: | 563.64 |
InChI: | InChI=1/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38) |
Molecular Structure: |
|
Properties |
Density: | 1.264g/cm3 |
Refractive index: | 1.644 |
Appearance: | Yellow Solid |
Usage: | A prototypical BCRP inhibitor. Inhibits the Bcrp1-mediated transport. |
Safety Data |
|
|